Dr. Noemi Reguart earned her Medical Degree from the University of Medicine Lleida, in Spain. She completed her postgraduate training and fellowship in the Oncology Department at Hospital Clinic Barcelona. Dr. Reguart gained a PhD focusing on molecular lung cancer biology at the General Thoracic Surgery and Oncology Laboratory, at the University of California San Francisco (UCSF). She has practiced as a Consultant Oncologist at the Department of Medical Oncology in Hospital Clinic Barcelona since 2008. She is a Clinical Professor at the University of Barcelona, deeply committed to under- and postgraduate teaching. Most recently Dr. Reguart has been designated the Director of the Thoracic Oncology Unit at the Hospital Clínic. Throughout her career, Dr. Reguart has shown her interest in addressing lung cancer. She has been involved in the design and patient recruitment to many personalized lung cancer trials. In addition to clinical practice and patient care, she also conducts basic research with a special interest in lung cancer biomarkers and the identification of predictors of therapy response at the Translational Genomics and Targeted Therapeutics in Solid Tumors Laboratory in August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona. She has always maintained an active research interest in her own laboratory as well as through several national and international collaborations. Dr. Reguart is an active member of several international lung cancer organizations including the European Society for Medical Oncology (ESMO), the International Association for the Study of Lung Cancer (IASLC) and the Spanish Lung Cancer Group (SLCG). She is a member of the Board of Directors the Lung Cancer Group of the European Organization for Research and Treatment of Cancer (EORTC) and the author of several scientific publications with an H-Score of 44